Curious About Your Ancestry? Submit a DNA Swab, and a Big Grain of Salt
By Maud Newton,
The New York Times
| 06. 18. 2018
By now, millions of us have taken ancestry tests. We’ve spit into tubes and allowed our genetic information to be uploaded into databases. In return we’ve had our genomes assigned to different parts of the world. The fine print warns us not to rely on those results, despite their seeming precision: 0.1 percent Oceanian! It’s hard to resist telling friends and family that we’ve turned out to be partly sub-Saharan African or Middle Eastern or Scandinavian. But testing with a different company may yield different results, or we may log into our account one day and find that the allocations have changed. Often the tests create as many mysteries as they solve.
The explanations that testing companies give for these shifts tend to be passive and blandly opaque: Identifying “ancestry-informative markers” depends on “sufficient data” from “reference populations.” Errors are “noise.” In her smart, searching new book, “Futureface: A Family Mystery, an Epic Quest, and the Secret to Belonging,” the journalist and former MSNBC host Alex Wagner recounts being incorrectly assigned enough Scandinavian DNA that one of her grandparents could...
Related Articles
By Alex Aylward, Daniel J. Fairbanks, Maria Kiladi, and Gregory Radick , Heredity | 04.20.2026
Genetics and eugenics co-evolved at the beginning of the twentieth century and remained associated through the 1940s and beyond. Early geneticists were far from unanimous in their views on eugenics; some avidly supported the movement, whereas others openly opposed it...
By Staff, GMWatch | 03.28.2026
Following a recent podcast interview we were asked whether there is any solid scientific research looking at how gene expression or molecular composition in genetically modified (GM) plants differs from conventionally bred plants. As this is an interesting and important...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...